Bottom line: Ask your clinician what to expect, how youll monitor progress, and when to adjust
Lilly's recently released research data indicates that all doses of Retatrutide significantly reduced liver fat content at week 48 compared to the placebo group
GLOWs collagen-boosting effects from GHK-Cu become noticeable, with many researchers reporting firmer skin in areas that were beginning to look loose
This specific property has become the focus of numerous research strategies, such as the development of senolytic agents like FOXO4-DRI, which selectively disrupt the FOXO4p53 interaction, thereby enabling the targeted elimination of dysfunctional cells
Alcohol deserves special consideration while taking GLP-1 medications
Grover K, Koblova A, Pezacki AT, Chang CJ, New EJ